Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

NCT01121640 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT01121640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01121640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2009
Completion date
May 7, 2015
Enrollment
854 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer